Abivax

Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic... Wikipedia

• Type:  Public (Société Anonyme)
• Traded as:  Euronext: ABVX, CAC Small
• ISIN:  [ ISIN: [ FR0012333284]]
• Industry:  Biotechnology, Pharmaceutical
• Founded:  December 04, 2013
• Founder:  Phillipe Pouletty
• Key people:  Marc de Garidel (CEO)
• Data source:  DuckDuckGo